Voglibose

# Voglibose ## Overview - **Classification**: Alpha-glucosidase inhibitor - **Mechanism**: Reversibly inhibits alpha-glucosidase enzymes in the small intestine, delaying carbohydrate digestion and glucose absorption, which reduces postprandial glucose excursions. ## Primary Indications 1. **Type 2 Diabetes Mellitus** - Management of postprandial hyperglycemia. 2. **Impaired Glucose Tolerance (IGT)** - To prevent or delay progression to Type 2 DM (specific regions). ## Adult Dosing ### Standard Dosing **Type 2 Diabetes Mellitus / Impaired Glucose Tolerance** - **Dose**: **0.2 mg** or **0.3 mg** - **Frequency**: 3 times daily - **Route**: Oral - **Special Considerations**: Must be taken **immediately before each main meal**. - **Maximum Daily Dose**: **0.9 mg/day** (0.3 mg three times daily) ### Dose Adjustments - **Renal Impairment**: Use with caution. Generally **contraindicated in severe renal impairment**. - **Hepatic Impairment**: Use with caution. Generally **contraindicated in severe hepatic impairment**. - **Elderly Patients**: No specific dose adjustment generally required, but monitor closely for adverse effects due to potential for reduced renal/hepatic function. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: Safety and efficacy **not established**. - **Special Notes**: **Not recommended** for use in neonates. ### Infants (1-12 months) - **Dose**: Safety and efficacy **not established**. - **Special Notes**: **Not recommended** for use in infants. ### Children (1-12 years) - **Dose**: Safety and efficacy **not established**. - **Special Notes**: **Not recommended** for use in children. ### Adolescents (13-18 years) - **Dose**: Safety and efficacy **not established**. - **Special Notes**: Generally **not recommended**. If considered in exceptional cases by specialists (off-label), adult dosing of **0.2 mg** or **0.3 mg** 3 times daily before meals might be used with extreme caution, but specific data are lacking. - **Maximum**: **0.9 mg/day** (if used, refer to adult max). ## Safety Information ### Contraindications - **Absolute**: Diabetic ketoacidosis. - **Absolute**: Severe infection, severe trauma, or major surgery. - **Absolute**: Severe renal or hepatic impairment. - **Absolute**: Inflammatory bowel disease, chronic intestinal disease, colonic ulceration, ileus. - **Absolute**: Pregnancy and lactation. - **Absolute**: Hypersensitivity to voglibose or excipients. ### Common Adverse Effects - **Very Common (>10%)**: Flatulence, abdominal distension. - **Common (1-10%)**: Diarrhea, abdominal pain. - **Serious but Rare**: Fulminant hepatitis, severe hypoglycemia (especially when co-administered with sulfonylureas or insulin), paralytic ileus. ### Key Drug Interactions - **Sulfonylureas/Insulin**: Increased risk of hypoglycemia. - **Clinical Significance**: If hypoglycemia occurs, **treat with glucose (dextrose)**, *not* sucrose (table sugar). - **Intestinal Adsorbents (e.g., activated charcoal)**: May reduce voglibose efficacy. - **Digestive Enzyme Preparations**: May reduce voglibose efficacy. - **Diuretics, Corticosteroids, Thyroid Hormones, Oral Contraceptives**: May reduce voglibose's hypoglycemic effect, requiring increased glucose monitoring. ## Monitoring & Follow-up - **Before Treatment**: HbA1c, fasting plasma glucose, baseline renal function (CrCl), baseline hepatic function (ALT, AST). - **During Treatment**: HbA1c (every 3-6 months), postprandial glucose, periodic hepatic function (LFTs). - **Clinical Signs**: Monitor for severe gastrointestinal symptoms (persistent diarrhea, severe abdominal pain), or signs of liver injury (jaundice, dark urine). ## Clinical Pearls - 💡 **Timing is Key**: Voglibose must be taken **immediately before each main meal** for optimal efficacy. - 💡 **Hypoglycemia Treatment**: If hypoglycemia occurs (especially with insulin/sulfonylureas), treat with **glucose/dextrose**, as voglibose delays sucrose breakdown. - 💡 **GI Side Effects**: Start with the lowest dose and titrate slowly to minimize common GI side effects like flatulence and diarrhea. - 💡 **Patient Counseling**: Explain the importance of diet and exercise alongside medication. Advise patients on expected GI side effects and how to manage them. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.